HCA Healthcare, Inc.
HealthcareNYSE:HCA · New York Stock Exchange
+$8.24 today
Vol 0.74M · Avg 1.31M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$76.4B of revenue converted into $6.8B of net income for the selected period. Gross margin is 34.9% and net margin is 8.9%, showing how much revenue survives after costs and taxes. EPS is $29.08, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75.6B +7.1% | $70.6B +8.7% | $65.0B +7.9% | $60.2B +2.5% | $58.8B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $44.2B +5.5% | $41.9B +6.4% | $39.4B +6.3% | $37.1B +2.2% | $36.3B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $31.4B +9.4% | $28.7B +12.1% | $25.6B +10.4% | $23.2B +3.0% | $22.5B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 41.5% +0.9pp | 40.6% +1.2pp | 39.4% +0.9pp | 38.5% +0.2pp | 38.3% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $8.0B -74.3% | $31.2B +5.7% | $29.5B +6.5% | $27.7B +3.4% | $26.8B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $19.4B +7.0% | $18.1B +13.7% | $16.0B +12.9% | $14.1B +10.2% | $12.8B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $3.5B +6.4% | $3.3B +7.6% | $3.1B +3.6% | $3.0B +4.1% | $2.9B | $374.2M | $1.2B | $631.8M |
| EBITDA | $15.6B +12.3% | $13.9B +9.2% | $12.7B -4.3% | $13.3B -6.7% | $14.3B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 20.6% +1.0pp | 19.7% +0.1pp | 19.6% -2.5pp | 22.1% -2.2pp | 24.3% | 5.6% | 46.3% | 42.0% |
| Operating Income | $12.0B +13.4% | $10.5B +9.6% | $9.6B +6.3% | $9.1B -6.5% | $9.7B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 15.8% +0.9pp | 14.9% +0.1pp | 14.8% -0.2pp | 15.0% -1.4pp | 16.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $2.2B +9.1% | $2.1B +6.3% | $1.9B +11.4% | $1.7B +13.7% | $1.5B | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$2.1B -5.4% | -$2.0B -5.4% | -$1.9B -306.1% | -$473.0M -405.2% | $155.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $9.8B +15.4% | $8.5B +10.6% | $7.7B -10.2% | $8.6B -12.7% | $9.8B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 13.0% +0.9pp | 12.1% +0.2pp | 11.9% -2.4pp | 14.2% -2.5pp | 16.7% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $2.0B +9.9% | $1.9B +15.5% | $1.6B -7.5% | $1.7B -17.3% | $2.1B | $1.3B | -$1.6B | $745.2M |
| Net Income | $6.8B +17.8% | $5.8B +9.9% | $5.2B -7.1% | $5.6B -18.9% | $7.0B | $4.9B | $4.8B | $4.7B |
| Net Margin | 9.0% +0.8pp | 8.2% +0.1pp | 8.1% -1.3pp | 9.4% -2.5pp | 11.8% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $29 +28.5% | $22 +15.7% | $19 -1.0% | $19 -9.6% | $22 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $28 +29.0% | $22 +16.0% | $19 -1.0% | $19 -9.5% | $21 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $230.7M -10.8% | $258.6M -5.1% | $272.4M -6.2% | $290.3M -10.2% | $323.3M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $230.7M -11.9% | $261.8M -5.3% | $276.4M -6.2% | $294.7M -10.4% | $328.8M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Pfizer Inc.
NYSE:PFE
$148.95B
CVS Health Corporation
NYSE:CVS
$129.97B
Stryker Corporation
NYSE:SYK
$120.17B
Bristol-Myers Squibb Company
NYSE:BMY
$116.52B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$112.66B
GSK plc
NYSE:GSK
$106.56B
Sanofi
NASDAQ:SNY
$106.45B
Medtronic plc
NYSE:MDT
$103.00B
McKesson Corporation
NYSE:MCK
$94.93B
Tenet Healthcare Corporation
NYSE:THC
$15.28B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does HCA generate?
HCA Healthcare, Inc. (HCA) reported $75.60B of revenue in fiscal 2025.
Is HCA profitable?
HCA Healthcare, Inc. (HCA) reported $6.78B of net income, with a net margin of 9.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.